_id
690da7f8ccc777a4e85d07ad
Ticker
AAVXF
Name
ABIVAX Société Anonyme
Exchange
PINK
Address
7-11 boulevard Haussmann, Paris, France, 75009
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.abivax.com
Description
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Last Close
120.85
Volume
100
Current Price
120.85
Change
0.19
Last Updated
2026-01-21T18:27:43.647Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
9479974912
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9702
Sentiment Sources
5
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
80712000
Operating Income
-80712000
Interest Expense
4213000
Pretax Income
-153358000
Net Income
-153358000
Eps
-1.97042101993822
Dividends Per Share
0
Shares Outstanding
78444148
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-23502000
Cash
589703000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
619295000
Property Plant Equipment
1914000
Total Assets
652052000
Payables
14355000
Short Term Debt
-
Long Term Debt
15878000
Total Liabilities
140814000
Equity
511238000
Bs_currency_symbol
EUR
Depreciation
272000
Change In Working Capital
-2075000
Cash From Operations
-71283000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
603460000
Net Change In Cash
528756000
Cf_currency_symbol
EUR
PE
-
PB
18.39801344373853
ROE
-29.997378911583255
ROA
-23.51928987258685
FCF
-71283000
Fcf Percent
-
Piotroski FScore
1
Health Score
27
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
80712000
Quarters > 0 > income Statement > operating Income
-80712000
Quarters > 0 > income Statement > interest Expense
4213000
Quarters > 0 > income Statement > pretax Income
-153358000
Quarters > 0 > income Statement > net Income
-153358000
Quarters > 0 > income Statement > eps
-1.97042101993822
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
77830067
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-23502000
Quarters > 0 > income Statement > currency_symbol
EUR
Quarters > 0 > balance Sheet > cash
589703000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
619295000
Quarters > 0 > balance Sheet > property Plant Equipment
1914000
Quarters > 0 > balance Sheet > total Assets
652052000
Quarters > 0 > balance Sheet > payables
14355000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
15878000
Quarters > 0 > balance Sheet > total Liabilities
140814000
Quarters > 0 > balance Sheet > equity
511238000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
-153358000
Quarters > 0 > cash Flow > depreciation
272000
Quarters > 0 > cash Flow > change In Working Capital
-2075000
Quarters > 0 > cash Flow > cash From Operations
-71283000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
603460000
Quarters > 0 > cash Flow > net Change In Cash
528756000
Quarters > 0 > cash Flow > currency_symbol
EUR
Quarters > 0 > ratios > PE
-1.97042101993822
Quarters > 0 > ratios > PB
18.39801344373853
Quarters > 0 > ratios > ROE
-29.997378911583255
Quarters > 0 > ratios > ROA
-23.51928987258685
Quarters > 0 > ratios > FCF
-71283000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
27
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
2017000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
2017000
Quarters > 1 > income Statement > operating Expenses
95713000
Quarters > 1 > income Statement > operating Income
-93696000
Quarters > 1 > income Statement > interest Expense
7007000
Quarters > 1 > income Statement > pretax Income
-100784000
Quarters > 1 > income Statement > net Income
-100784000
Quarters > 1 > income Statement > eps
-1.5894101229452509
Quarters > 1 > income Statement > dividends Per Share
0
Quarters > 1 > income Statement > shares Outstanding
63409688
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-93594000
Quarters > 1 > income Statement > operating Margin
-4645.314823996034
Quarters > 1 > income Statement > total Other Income Expense Net
-7088000
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
60946000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
86102000
Quarters > 1 > balance Sheet > property Plant Equipment
2159000
Quarters > 1 > balance Sheet > total Assets
119641000
Quarters > 1 > balance Sheet > payables
57497000
Quarters > 1 > balance Sheet > short Term Debt
48844000
Quarters > 1 > balance Sheet > long Term Debt
34782000
Quarters > 1 > balance Sheet > total Liabilities
167921000
Quarters > 1 > balance Sheet > equity
-48280000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-100784000
Quarters > 1 > cash Flow > depreciation
524000
Quarters > 1 > cash Flow > change In Working Capital
2287000
Quarters > 1 > cash Flow > cash From Operations
-66617999
Quarters > 1 > cash Flow > capital Expenditures
63000
Quarters > 1 > cash Flow > cash From Investing
1269000
Quarters > 1 > cash Flow > cash From Financing
-16604000
Quarters > 1 > cash Flow > net Change In Cash
60946000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-1.5894101229452509
Quarters > 1 > ratios > PB
-158.72122607290802
Quarters > 1 > ratios > ROE
208.7489643744822
Quarters > 1 > ratios > ROA
-84.23868071982012
Quarters > 1 > ratios > FCF
-66680999
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-33.059493802677245
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
47200000
Quarters > 2 > income Statement > operating Income
-47200000
Quarters > 2 > income Statement > interest Expense
4535000
Quarters > 2 > income Statement > pretax Income
-52370000
Quarters > 2 > income Statement > net Income
-52370000
Quarters > 2 > income Statement > eps
-0.8257810320414867
Quarters > 2 > income Statement > dividends Per Share
0
Quarters > 2 > income Statement > shares Outstanding
63418749
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-904000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
103576000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
132667000
Quarters > 2 > balance Sheet > property Plant Equipment
2410000
Quarters > 2 > balance Sheet > total Assets
166939000
Quarters > 2 > balance Sheet > payables
56525000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
47001000
Quarters > 2 > balance Sheet > total Liabilities
173532000
Quarters > 2 > balance Sheet > equity
-6593000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-52400000
Quarters > 2 > cash Flow > depreciation
273000
Quarters > 2 > cash Flow > change In Working Capital
9011000
Quarters > 2 > cash Flow > cash From Operations
-33278000
Quarters > 2 > cash Flow > capital Expenditures
44000
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-7838000
Quarters > 2 > cash Flow > net Change In Cash
-40646000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-0.8257810320414867
Quarters > 2 > ratios > PB
-1162.4686510920671
Quarters > 2 > ratios > ROE
794.3273168512059
Quarters > 2 > ratios > ROA
-31.370740210496052
Quarters > 2 > ratios > FCF
-33322000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
4006000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
4006000
Quarters > 3 > income Statement > operating Expenses
96993000
Quarters > 3 > income Statement > operating Income
-92987000
Quarters > 3 > income Statement > interest Expense
1105000
Quarters > 3 > income Statement > pretax Income
-94604000
Quarters > 3 > income Statement > net Income
-94604000
Quarters > 3 > income Statement > eps
-1.4975148003925665
Quarters > 3 > income Statement > dividends Per Share
0
Quarters > 3 > income Statement > shares Outstanding
63174000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-92058000
Quarters > 3 > income Statement > operating Margin
-2321.193210184723
Quarters > 3 > income Statement > total Other Income Expense Net
-1617000
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
144221000
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
15663000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
170671000
Quarters > 3 > balance Sheet > property Plant Equipment
2665000
Quarters > 3 > balance Sheet > total Assets
205228000
Quarters > 3 > balance Sheet > payables
43824000
Quarters > 3 > balance Sheet > short Term Debt
43769000
Quarters > 3 > balance Sheet > long Term Debt
52161000
Quarters > 3 > balance Sheet > total Liabilities
164644000
Quarters > 3 > balance Sheet > equity
40584000
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-94604000
Quarters > 3 > cash Flow > depreciation
524000
Quarters > 3 > cash Flow > change In Working Capital
-2600000
Quarters > 3 > cash Flow > cash From Operations
-68897000
Quarters > 3 > cash Flow > capital Expenditures
407000
Quarters > 3 > cash Flow > cash From Investing
2304000
Quarters > 3 > cash Flow > cash From Financing
-12115000
Quarters > 3 > cash Flow > net Change In Cash
-78096000
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-1.4975148003925665
Quarters > 3 > ratios > PB
188.11792578356
Quarters > 3 > ratios > ROE
-233.10664301202445
Quarters > 3 > ratios > ROA
-46.09702379792231
Quarters > 3 > ratios > FCF
-69304000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-17.300049925112333
Quarters > 3 > health Score
8
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
10792000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
10792000
Annuals > 0 > income Statement > operating Expenses
183776000
Annuals > 0 > income Statement > operating Income
-172984000
Annuals > 0 > income Statement > interest Expense
4184999
Annuals > 0 > income Statement > pretax Income
-176242000
Annuals > 0 > income Statement > net Income
-176242000
Annuals > 0 > income Statement > eps
-2.7954509405830663
Annuals > 0 > income Statement > dividends Per Share
0
Annuals > 0 > income Statement > shares Outstanding
63046000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-171883000
Annuals > 0 > income Statement > operating Margin
-1602.8910303928835
Annuals > 0 > income Statement > total Other Income Expense Net
-3258000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
144221000
Annuals > 0 > balance Sheet > short Term Investments
136000
Annuals > 0 > balance Sheet > receivables
15663000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
170671000
Annuals > 0 > balance Sheet > property Plant Equipment
2665000
Annuals > 0 > balance Sheet > total Assets
205228000
Annuals > 0 > balance Sheet > payables
43824000
Annuals > 0 > balance Sheet > short Term Debt
43769000
Annuals > 0 > balance Sheet > long Term Debt
52161000
Annuals > 0 > balance Sheet > total Liabilities
164644000
Annuals > 0 > balance Sheet > equity
40584000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-176242000
Annuals > 0 > cash Flow > depreciation
1100000
Annuals > 0 > cash Flow > change In Working Capital
1423000
Annuals > 0 > cash Flow > cash From Operations
-154072000
Annuals > 0 > cash Flow > capital Expenditures
643000
Annuals > 0 > cash Flow > cash From Investing
15762000
Annuals > 0 > cash Flow > cash From Financing
28207000
Annuals > 0 > cash Flow > net Change In Cash
-107721000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-2.7954509405830663
Annuals > 0 > ratios > PB
187.7367706485314
Annuals > 0 > ratios > ROE
-434.26473487088504
Annuals > 0 > ratios > ROA
-85.87619623053384
Annuals > 0 > ratios > FCF
-154715000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-14.33608228317272
Annuals > 0 > health Score
8
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
4621000
Annuals > 1 > income Statement > cost Of Revenue
128000
Annuals > 1 > income Statement > gross Profit
4493000
Annuals > 1 > income Statement > operating Expenses
127376000
Annuals > 1 > income Statement > operating Income
-127376000
Annuals > 1 > income Statement > interest Expense
13826000
Annuals > 1 > income Statement > pretax Income
-152233000
Annuals > 1 > income Statement > net Income
-147740000
Annuals > 1 > income Statement > eps
-3.4305475046075777
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
43066012
Annuals > 1 > income Statement > income Tax Expense
-4493000
Annuals > 1 > income Statement > EBITDA
-133207000
Annuals > 1 > income Statement > operating Margin
-2756.4596407703957
Annuals > 1 > income Statement > total Other Income Expense Net
-24857000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
251942000
Annuals > 1 > balance Sheet > short Term Investments
9050000
Annuals > 1 > balance Sheet > receivables
19099000
Annuals > 1 > balance Sheet > inventories
-137000
Annuals > 1 > balance Sheet > total Current Assets
285972000
Annuals > 1 > balance Sheet > property Plant Equipment
878000
Annuals > 1 > balance Sheet > total Assets
327062000
Annuals > 1 > balance Sheet > payables
47221000
Annuals > 1 > balance Sheet > short Term Debt
14116000
Annuals > 1 > balance Sheet > long Term Debt
44697000
Annuals > 1 > balance Sheet > total Liabilities
131052000
Annuals > 1 > balance Sheet > equity
196010000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-147740000
Annuals > 1 > cash Flow > depreciation
707000
Annuals > 1 > cash Flow > change In Working Capital
21265000
Annuals > 1 > cash Flow > cash From Operations
-97130000
Annuals > 1 > cash Flow > capital Expenditures
265000
Annuals > 1 > cash Flow > cash From Investing
-8095000
Annuals > 1 > cash Flow > cash From Financing
335290000
Annuals > 1 > cash Flow > net Change In Cash
224992000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-3.4305475046075777
Annuals > 1 > ratios > PB
26.552357278710268
Annuals > 1 > ratios > ROE
-75.37370542319269
Annuals > 1 > ratios > ROA
-45.17186343873639
Annuals > 1 > ratios > FCF
-97395000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-21.076606795066002
Annuals > 1 > health Score
23
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
4583000
Annuals > 2 > income Statement > cost Of Revenue
71000
Annuals > 2 > income Statement > gross Profit
4512000
Annuals > 2 > income Statement > operating Expenses
56575000
Annuals > 2 > income Statement > operating Income
-56646000
Annuals > 2 > income Statement > interest Expense
3934000
Annuals > 2 > income Statement > pretax Income
-74322000
Annuals > 2 > income Statement > net Income
-69846000
Annuals > 2 > income Statement > eps
-3.1319411950530878
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
22301185
Annuals > 2 > income Statement > income Tax Expense
-4476000
Annuals > 2 > income Statement > EBITDA
-53315000
Annuals > 2 > income Statement > operating Margin
-1236.0026183722453
Annuals > 2 > income Statement > total Other Income Expense Net
-380000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
26944000
Annuals > 2 > balance Sheet > short Term Investments
6000
Annuals > 2 > balance Sheet > receivables
8316000
Annuals > 2 > balance Sheet > inventories
12187000
Annuals > 2 > balance Sheet > total Current Assets
48191000
Annuals > 2 > balance Sheet > property Plant Equipment
322000
Annuals > 2 > balance Sheet > total Assets
73352000
Annuals > 2 > balance Sheet > payables
15475000
Annuals > 2 > balance Sheet > short Term Debt
10702000
Annuals > 2 > balance Sheet > long Term Debt
36575000
Annuals > 2 > balance Sheet > total Liabilities
71470000
Annuals > 2 > balance Sheet > equity
1882000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-69846000
Annuals > 2 > cash Flow > depreciation
71000
Annuals > 2 > cash Flow > change In Working Capital
-10089000
Annuals > 2 > cash Flow > cash From Operations
-65579000
Annuals > 2 > cash Flow > capital Expenditures
3968000
Annuals > 2 > cash Flow > cash From Investing
-3727000
Annuals > 2 > cash Flow > cash From Financing
35556000
Annuals > 2 > cash Flow > net Change In Cash
-33751000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-3.1319411950530878
Annuals > 2 > ratios > PB
1432.0394299946865
Annuals > 2 > ratios > ROE
-3711.2646121147714
Annuals > 2 > ratios > ROA
-95.22030755807613
Annuals > 2 > ratios > FCF
-69547000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-15.174994545057823
Annuals > 2 > health Score
8
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
37000
Annuals > 3 > income Statement > cost Of Revenue
156000
Annuals > 3 > income Statement > gross Profit
-119000
Annuals > 3 > income Statement > operating Expenses
52031000
Annuals > 3 > income Statement > operating Income
-52187000
Annuals > 3 > income Statement > interest Expense
3558000
Annuals > 3 > income Statement > pretax Income
-45561000
Annuals > 3 > income Statement > net Income
-41357000
Annuals > 3 > income Statement > eps
-2.4682713703140546
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
16755451
Annuals > 3 > income Statement > income Tax Expense
-4204000
Annuals > 3 > income Statement > EBITDA
-38738000
Annuals > 3 > income Statement > operating Margin
-141045.94594594595
Annuals > 3 > income Statement > total Other Income Expense Net
6626000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
60695000
Annuals > 3 > balance Sheet > short Term Investments
6000
Annuals > 3 > balance Sheet > receivables
8339000
Annuals > 3 > balance Sheet > inventories
4000000
Annuals > 3 > balance Sheet > total Current Assets
74713000
Annuals > 3 > balance Sheet > property Plant Equipment
93000
Annuals > 3 > balance Sheet > total Assets
110365000
Annuals > 3 > balance Sheet > payables
18558000
Annuals > 3 > balance Sheet > short Term Debt
10232000
Annuals > 3 > balance Sheet > long Term Debt
53445000
Annuals > 3 > balance Sheet > total Liabilities
81591000
Annuals > 3 > balance Sheet > equity
28774000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-41357000
Annuals > 3 > cash Flow > depreciation
156000
Annuals > 3 > cash Flow > change In Working Capital
-1414000
Annuals > 3 > cash Flow > cash From Operations
-45657000
Annuals > 3 > cash Flow > capital Expenditures
1642000
Annuals > 3 > cash Flow > cash From Investing
-1456000
Annuals > 3 > cash Flow > cash From Financing
78512000
Annuals > 3 > cash Flow > net Change In Cash
31399000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-2.4682713703140546
Annuals > 3 > ratios > PB
70.37242835024675
Annuals > 3 > ratios > ROE
-143.73045110168903
Annuals > 3 > ratios > ROA
-37.47293072985095
Annuals > 3 > ratios > FCF
-47299000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-1278.3513513513512
Annuals > 3 > health Score
13
Valuation > metrics > PE
-1.97042101993822
Valuation > metrics > PB
18.39801344373853
Valuation > final Score
20
Valuation > verdict
513.3% Overvalued
Profitability > metrics > ROE
-29.997378911583255
Profitability > metrics > ROA
-24.763319581136614
Profitability > metrics > Net Margin
-
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.2754372718772861
Risk > metrics > Interest Coverage
-19.157844766199858
Risk > final Score
-17
Risk > verdict
High
Liquidity > metrics > Current Ratio
43.14141414141414
Liquidity > metrics > Quick Ratio
43.14141414141414
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
20
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
0
Prev Risks > 0
-23
Prev Risks > 1
-12
Prev Risks > 2
-331
Prev Liquidities > 0
50
Prev Liquidities > 1
100
Prev Liquidities > 2
50
Updated At
2026-01-21T18:27:44.401Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-23
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-09-30
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-2.4568
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-09-08
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.8657
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.8697
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-09-30
Earnings History > 4 > report Date
2020-12-31
Earnings History > 4 > date
2020-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
-0.9447
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.9447
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-06-30
Earnings History > 5 > report Date
2020-09-30
Earnings History > 5 > date
2020-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
-0.9068
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.9068
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2020-03-31
Earnings History > 6 > report Date
2020-06-30
Earnings History > 6 > date
2020-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.7096
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.7096
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-12-31
Earnings History > 7 > report Date
2020-03-31
Earnings History > 7 > date
2019-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.6959
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.6959
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-09-30
Earnings History > 8 > report Date
2019-12-31
Earnings History > 8 > date
2019-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.758
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.758
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-06-30
Earnings History > 9 > report Date
2019-09-30
Earnings History > 9 > date
2019-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-0.7366
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.7366
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-03-31
Earnings History > 10 > report Date
2019-06-30
Earnings History > 10 > date
2019-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.7868
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.7868
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-12-31
Earnings History > 11 > report Date
2019-03-31
Earnings History > 11 > date
2018-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-0.7761
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.7761
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-09-30
Earnings History > 12 > report Date
2018-12-31
Earnings History > 12 > date
2018-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-0.4829
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.4829
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-06-30
Earnings History > 13 > report Date
2018-09-30
Earnings History > 13 > date
2018-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-0.4893
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.4893
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2018-03-31
Earnings History > 14 > report Date
2018-06-30
Earnings History > 14 > date
2018-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-0.4238
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.4238
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-12-31
Earnings History > 15 > report Date
2018-03-31
Earnings History > 15 > date
2017-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-0.4471
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.4471
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-09-30
Earnings History > 16 > report Date
2017-12-31
Earnings History > 16 > date
2017-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-0.3448
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.3448
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-06-30
Earnings History > 17 > report Date
2017-09-30
Earnings History > 17 > date
2017-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
-0.3397
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.3397
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2017-03-31
Earnings History > 18 > report Date
2017-06-30
Earnings History > 18 > date
2017-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
-0.3264
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.3264
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2016-12-31
Earnings History > 19 > report Date
2017-03-15
Earnings History > 19 > date
2016-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
-0.3049
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.3049
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2016-09-30
Earnings History > 20 > report Date
2016-12-31
Earnings History > 20 > date
2016-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
-0.329
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.329
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2016-06-30
Earnings History > 21 > report Date
2016-09-20
Earnings History > 21 > date
2016-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
-0.3511
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.3511
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2016-03-31
Earnings History > 22 > report Date
2016-06-30
Earnings History > 22 > date
2016-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
EUR
Earnings History > 22 > eps Actual
-0.4761
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.4761
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2015-12-31
Earnings History > 23 > report Date
2016-03-15
Earnings History > 23 > date
2015-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
EUR
Earnings History > 23 > eps Actual
-0.4882
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.4882
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2015-09-30
Earnings History > 24 > report Date
2015-12-31
Earnings History > 24 > date
2015-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
EUR
Earnings History > 24 > eps Actual
-0.4942
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.4942
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2015-06-30
Earnings History > 25 > report Date
2015-09-29
Earnings History > 25 > date
2015-06-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
EUR
Earnings History > 25 > eps Actual
-0.5078
Earnings History > 25 > eps Estimate
-0.32
Earnings History > 25 > eps Difference
-0.1878
Earnings History > 25 > surprise Percent
-58.6875
Earnings History > 26 > period
2015-03-31
Earnings History > 26 > report Date
2015-06-09
Earnings History > 26 > date
2015-03-31
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
EUR
Earnings History > 26 > eps Actual
-0.4149
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.4149
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2014-12-31
Earnings History > 27 > report Date
2015-03-31
Earnings History > 27 > date
2014-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
EUR
Earnings History > 27 > eps Actual
-0.4002
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.4002
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2014-09-30
Earnings History > 28 > report Date
2014-12-31
Earnings History > 28 > date
2014-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
EUR
Earnings History > 28 > eps Actual
-0.3875
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.3875
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2014-06-30
Earnings History > 29 > report Date
2014-09-30
Earnings History > 29 > date
2014-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
EUR
Earnings History > 29 > eps Actual
-0.404
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.404
Earnings History > 29 > surprise Percent
-
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AABIVAX Société Anonyme (AAVXF) Price Target Increased by 13.99% to 140.24 Nasdaq
Read more →Abivax: "Strong Buy" On Obefazimod New UC Data And Maintenance Results Coming Q2 2026 Seeking Alpha
Read more →Showing 2 of 7
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of ABIVAX Société Anonyme
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
-2.4568
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.